Brief: Champions Oncology posts Q3 adj. loss per share $0.11

Champions Oncology

16/03/2017 20:01

March 16 (Reuters) - Champions Biotechnology  Inc  CSBR.O  
    * Champions Oncology reports 40 pct revenue growth 
    * Q3 revenue rose 39.7 percent to $3.6 million 
    * For Q3 of fiscal 2017, champions reported a loss from 
operations of $1.4 million 
    * Qtrly non-GAAP loss per share $ 0.11 
    * Qtrly GAAP loss per share $0.13 
    * Qtrly non-GAAP loss per share $0.11 
    * Champions Biotechnology Inc - company ended quarter with 
$3.5 million of cash and cash equivalents on balance sheet 
 
Source text for Eikon:  ID:nPn4p2Mrka  
Further company coverage:  CSBR.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))